Literature DB >> 2841880

Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children.

Y Y Xin1, Z G Ming, G Y Peng, A Jian, L H Min.   

Abstract

In a study begun in 1985, 1,026 children between the ages of 5 and 12 years, living in an area of low Japanese encephalitis (JE) infection, were vaccinated with live-attenuated JE vaccine, strain SA14-14-2. A group of 47 of the vaccinated children, 5-6 years of age, were examined for fever and other systemic reactions every other day for 2 weeks following vaccination. None of these children had temperatures greater than 37.4 degrees C or other systemic reactions during the observation period. No untoward reactions were reported in the remainder of the vaccinated group. After immunization, seroconversion rates in seronegative children were 100% (GMT 35.3, n = 11), 100% (GMT 31.7, n = 12), and 83.3% (GMT 23, n = 10) in groups receiving vaccine diluted 1:3, 1:5, and 1:50, respectively. These results indicate that the JE SA14-14-2 live-attenuated vaccine is immunogenic and safe for children.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841880     DOI: 10.4269/ajtmh.1988.39.214

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  39 in total

Review 1.  Immunogenicity and safety of currently available Japanese encephalitis vaccines: a systematic review.

Authors:  Xing Li; Shu-Juan Ma; Xie Liu; Li-Na Jiang; Jun-Hua Zhou; Yi-Quan Xiong; Hong Ding; Qing Chen
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  A novel low-cost approach to estimate the incidence of Japanese encephalitis in the catchment area of three hospitals in Bangladesh.

Authors:  Repon C Paul; Mahmudur Rahman; Emily S Gurley; M Jahangir Hossain; Serguei Diorditsa; Asm Mainul Hasan; Sultana S Banu; Asm Alamgir; Muhammad Aziz Rahman; Hardeep Sandhu; Marc Fischer; Stephen P Luby
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

Review 3.  Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.

Authors:  Amy Sarah Ginsburg; Ankita Meghani; Scott B Halstead; Mansour Yaich
Journal:  Hum Vaccin Immunother       Date:  2017-08-25       Impact factor: 3.452

4.  Etiological spectrum of clinically diagnosed Japanese encephalitis cases reported in Guizhou Province, China, in 2006.

Authors:  Ye Xufang; Wang Huanyu; Fu Shihong; Gao Xiaoyan; Zhao Shuye; Liu Chunting; Li Minghua; Zhai Yougang; Liang Guodong
Journal:  J Clin Microbiol       Date:  2010-02-10       Impact factor: 5.948

5.  Immunogenicity of a live-attenuated Japanese encephalitis vaccine in children and adolescents after hematopoietic stem cell transplantation.

Authors:  S Pakakasama; S Wattanatitan; C Techasaensiri; S Yoksan; S Sirireung; S Hongeng
Journal:  Bone Marrow Transplant       Date:  2014-07-21       Impact factor: 5.483

6.  Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines.

Authors:  H W Chen; C H Pan; M Y Liau; R Jou; C J Tsai; H J Wu; Y L Lin; M H Tao
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 7.  Recent advances in Japanese encephalitis.

Authors:  Tom Solomon
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

8.  Inhibition of Japanese encephalitis virus infection by the sulfated polysaccharide extracts from Ulva lactuca.

Authors:  Ya-Huang Chiu; Yi-Lin Chan; Tsung-Lin Li; Chang-Jer Wu
Journal:  Mar Biotechnol (NY)       Date:  2011-12-23       Impact factor: 3.619

9.  Main Factors Influencing the Efficient Propagation of Virulent or Attenuated Strains of Japanese encephalitis virus in BHK-21 Cells.

Authors:  Man Teng; Jun Luo; Guang-Xu Xing; Na Cheng; Yan-Yan Yang; Rui-Guang Deng; Gai-Ping Zhang
Journal:  Indian J Virol       Date:  2012-09-12

10.  Engineering the Japanese encephalitis virus RNA genome for the expression of foreign genes of various sizes: implications for packaging capacity and RNA replication efficiency.

Authors:  Sang-Im Yun; Yu-Jeong Choi; Xiao-Fang Yu; Jae-Young Song; Young-Hak Shin; Young-Ran Ju; Seok-Yong Kim; Young-Min Lee
Journal:  J Neurovirol       Date:  2007-12       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.